Back to Authors

Price, Daniel

Mayo Clinic

Department of Otolaryngology-Head and Neck Surgery, Mayo Clinic, Rochester, Minnesota, USA.

Citations 1

Human Papillomavirus–Associated Anogenital Pathology in Females With HPV‐Positive Oropharyngeal Squamous Cell Carcinoma
Larish, Alyssa , Moore, Eric J. , Routman, David M. , Janus, Jeffrey R. , Price, Katharine A. , Neben-Wittich, M.A. , Foote, Robert L. , Abel, Kathryn M. Van , Yin, Linda, Glaser, Gretchen , Moore, Eric, Bakkum-Gamez, Jamie, Routman, David, Ma, Daniel, Price, Daniel, Janus, Jeffrey, Price, Katharine, Chintakuntlawar, Ashish, Neben-Wittich, Michelle, Foote, Robert, Van Abel, Kathryn, Van Abel, Kathryn M , Routman, David M , Yin, Linda X. , Bakkum‐Gamez, Jamie N. , Daniel, J. , Price, Daniel L. , Chintakuntlawar, Ashish V.

Otolaryngology–Head and Neck Surgery | July 14, 2020 | Volume: 164 | Issue: 2 | Pages: 369-374

10.1177/0194599820941499 Get It

We sought to determine the incidence and location of human papillomavirus (HPV)–associated anogenital disease in women with HPV‐positive oropharyngeal squamous cell carcinoma (OPSCC) via a retrospective cohort study with prospective contact to update history at Mayo Clinic in Rochester, Minnesota. Females undergoing treatment for nonmetastatic HPV‐positive OPSCC from 2011 to 2019 were identified. Clinical history and outcomes were abstracted from medical records. Patients without documented anogenital history were contacted, consented, and administered a survey, and external records were requested and reviewed. Seventeen of 46 patients (37.0%) had a history of anogenital HPV‐associated disease, and 16 of 17 (94.1%) required procedures to diagnose or treat HPV lesions. The cervix was the most common site (16/17, 94.1%). Procedures included colposcopy (n = 6), cervical excision (n = 3), cryotherapy (n = 4), and hysterectomy (n = 3). One case of fatal cervical carcinoma was noted, diagnosed 1 year following OPSCC. Three of 17 (17.6%) had HPV‐related vulvovaginal disease, and 1 of 17 had anal disease. Patients with a history of HPV‐positive OPSCC may be at elevated risk for HPV‐associated anogenital disease.